defense he was subjected to mandatory HIV testing
and tested positive. The World Boxing Organization
stripped him of his title and refused to allow him to
compete (Johnston, 1994).REFERENCES
Armstrong W, Calabrese L, Taege A: HIV update 2002: Delaying
treatment to curb rising resistance. Clev Clin J Med
69(12):995–999, Dec. 2002.
Brown LS, Jr, Drotman DP, Chu A et al: Bleeding injuries in pro-
fessional football: Estimating the risk for HIV transmission.
Ann Intern Med122:271–274, 1995.
Dorman JM: Contagious diseases in competitive sport: what are
the risks? J Am Coll Health49(3):105–109, Nov. 2000.
Droge W, Holm E: Role of cysteine and glutathione in HIV infec-
tion and other diseases associated with muscle wasting and
immunologic dysfunction. FASEB J11(13):1077–1089, Nov.
1997.
Eichner ER, Calabrese LH: Immunology and exercise.
Physiology, pathophysiology, and implications for HIV infec-
tion. Med Clin North Am78(2):377–388, Mar. 1994.
Feller A, Flanigan TP: HIV-infected competitive athletes. What
are the risks? What precautions should be taken? J Gen Intern
Med12(4):243–246, Apr. 1997.
Field CJ, Johnson I, Pratt VC: Glutamine and argenine:
Immunonutrients for improved health. Med Sci Sports Exerc
32(7suppl):S377–S388, Jul. 2000.
Gerberding JL: Management of occupational exposures to blood-
borne viruses. NEJM332:444–451, 1995.
AAP: Human immunodeficiency virus and other blood-borne
viral pathogens in the athletic setting. Committee on Sports
Medicine and Fitness, American Academy of Pediatrics.
Pediatrics 104(6):1400–1403, Dec. 1999.
Johnston JL: Is mandatory HIV testing of professional athletes
really the solution? Case Western Reserve University School
of Law. Health Matrix Clevl4(1):159–203, Spring 1994.
Johnson RJ: HIV infection in athletes: What are the risks? Who
can compete? Postgrad Med92:73–75, 79–80, 1992.
Kokotailo PK, Koscik RE, Henry BC et al: Health risk taking and
human immunodeficiency virus risk in collegiate female ath-
letes. J Am Coll Health46(6):263–268, May 1998.
LaPerriere A, Fletcher MA, Antoni MH et al: Aerobic exercise
training in an AIDS risk group. Int J Sports Med12(Suppl 1):
S53–S57, 1991.
LeBlanc KE: The athlete and HIV. J La State Med Soc
145(11):493–495, Nov. 1993.
Mackinnon LT: Chronic exercise training effects on immune func-
tion. Med Sci Sports Exerc32(7suppl):S369–S376, Jul. 2000.
Mast EE, Goodman RA, Bond WW et al: Transmission of blood-
borne pathogens during sports: Risk and prevention. Ann
Intern Med122(4):283–285, Feb. 15, 1995.
McGrew CA, Dick RW, Schniedwind K et al: Survey of NCAA
institutions concerning HIV/AIDS policies and universal pre-
cautions. Med Sci Sports Exerc25(8):917–921, Aug. 1993.
Nattiv A, Puffer JC: Lifestyles and health risks of collegiate ath-
letes. J Fam Pract33:585–590, 1991.
NCAA Guideline 2h: Blood-borne pathogens and intercollegiate
athletics. Overland Park, KS, National Collegiate Athletic
Association, August 2000.
Jellin JM (ed.). Presc Lett10(4):23, Apr. 2003.
Stringer WW: Mechanisms of exercise limitation in HIV+
individuals. Med Sci Sports Exerc suppl:S412–S421, Apr.
2000.
Ullum H, Palmo J, Halkjaer-Kristensen J et al: The effect of acute
exercise on lymphocyte subsets, natural killer cells, prolifera-
tive responses, and cytokines in HIV-seropositive persons.
J AIDS7:1122–1132, 1994.608 SECTION 7 • SPECIAL POPULATIONS